Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in NXTC — NextCure, Inc.

CIK 19617 NEW YORK, NY
Back to NXTC Full portfolio

Position in NXTC

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$97
-$554 QoQ
Shares Held
61
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 30 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NXTC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. NXTC ranks #394 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in NXTC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $97 61
2026-03-31 $651 61
2025-12-31 $865 61
2025-09-30 $357 61
2025-06-30 $347 756
2025-03-31 $386 807
2024-12-31 $619 805
2024-09-30 $1,104 807
2024-06-30 $1,281 806
2024-03-31 $1,789 803
2023-12-31 $1,715 1,505
2023-09-30 $3,800 2,946
2023-06-30 $5,260 2,923
2023-03-31 $4,325 2,923
2022-12-31 $4,120 2,923
2022-09-30 $14,063 5,114
2022-06-30 $158,563 33,737
2022-03-31 $86,968 17,895
2021-12-31 $52,642 8,774
2021-09-30 $16,546 2,455
2021-06-30 $366,480 45,639
2021-03-31 $371,779 37,141
2020-12-31 $84,310 7,735
2020-09-30 $1,122,765 127,587
2020-06-30 $753,485 35,144
2020-03-31 $171,893 4,637